Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML-study IV

Show other versions (1)

Saved in:

Bibliographic Details
Other Authors:	Saußele, Susanne (Other) , Müller, Martin Christian (Other) , Hehlmann, Rüdiger (Other) , Dietz, Christian (Other) , Fabarius, Alice (Other) , Kalmanti, Lida (Other) , Hanfstein, Benjamin (Other) , Proetel, Ulrike (Other) , Rinaldetti, Sébastien (Other) , Hofmann, Wolf-Karsten (Other)
Format:	Article (Journal) Conference Paper
Language:	English
Published:	2014
In:	Blood Year: 2014, Volume: 124, Issue: 21
ISSN:	1528-0020
Subjects:	Konferenzschrift
Online Access:	Verlag, kostenfrei, Volltext: https://ash.confex.com/ash/2014/webprogram/Paper69967.html/
Author Notes:	Susanne Saussele, Rüdiger Hehlmann, Christian Dietz, Susanne Schnittger, Alice Charlotte Fabarius, Lida Kalmanti, Benjamin Hanfstein, Ulrike Proetel, Sebastien Rinaldetti, Hermann Einsele, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Michael Pfreundschuh, Frank Stegelmann, Cornelius F. Waller, Gabriela M. Baerlocher, Dominik Heim, Stefan W. Krause, Wolf-Karsten Hofmann, Joerg Hasford, Markus Pfirrmann, Andreas Hochhaus, Martin C. Müller, Michael Lauseker

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV by Saußele, Susanne (Author) , Hehlmann, Rüdiger (Author) , Fabarius, Alice (Author) , Rinaldetti, Sébastien (Author) , Kohlbrenner, Katharina (Author) , Hofmann, Wolf-Karsten (Author) , Müller, Martin Christian (Author) ,

in: Leukemia, 32 (2018), 5, Seite 1222-1228

Article (Journal) Online Resource